Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vera

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|February 22, 2021
Trimodality PET/CT/MRI and Radiotherapy: A Mini-ReviewPierre Decazes, Pauline Hinault, Ovidiu Veresezan, et al.
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
⁹⁹mTc-(Me)FGCDEVD, a potential tracer for apoptosis detectionPierre Bohn, Florian Mouchard, Jean Rouvet, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 26, 2018
Semi-automatic lymphoma detection and segmentation using fully conditional random fieldsYuntao Yu, Pierre Decazes, Jérôme Lapuyade-Lahorgue, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2017
Predictive value of <sup>18</sup>F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trialStéphanie Becker, Thomas Vermeulin, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 10, 2015
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancerJérémie Calais, Sébastien Thureau, Bernard Dubray, et al.
Plos One|October 12, 2019
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiationJulien Ganem, Sebastien Thureau, Pierrick Gouel, et al.
European Radiology|January 30, 2022
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumoursCaroline Dominique, Françoise Callonnec, Anca Berghian, et al.
Metabolites|February 3, 2021
Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?Florian Eude, Mathieu Nessim Toledano, Pierre Vera, et al.
Leukemia & Lymphoma|December 8, 2020
SUV<sub>max</sub>-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin's lymphomaEdgar Texte, Justine Lequesne, Hervé Tilly, et al.
Clinical Nuclear Medicine|December 14, 2020
Panniculitis in a Woman With Opportunistic Pulmonary Coinfection by Pneumocystis jirovecii and Cryptococcus neoformans: 18F-FDG PET/CT Revealing the Infection and Assessing Treatment ResponseBillal Tedbirt, Anne-Benedicte Duval-Modeste, Philippe Courville, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|February 22, 2021
Trimodality PET/CT/MRI and Radiotherapy: A Mini-ReviewPierre Decazes, Pauline Hinault, Ovidiu Veresezan, et al.
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
⁹⁹mTc-(Me)FGCDEVD, a potential tracer for apoptosis detectionPierre Bohn, Florian Mouchard, Jean Rouvet, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 26, 2018
Semi-automatic lymphoma detection and segmentation using fully conditional random fieldsYuntao Yu, Pierre Decazes, Jérôme Lapuyade-Lahorgue, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2017
Predictive value of <sup>18</sup>F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trialStéphanie Becker, Thomas Vermeulin, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 10, 2015
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancerJérémie Calais, Sébastien Thureau, Bernard Dubray, et al.
Plos One|October 12, 2019
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiationJulien Ganem, Sebastien Thureau, Pierrick Gouel, et al.
European Radiology|January 30, 2022
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumoursCaroline Dominique, Françoise Callonnec, Anca Berghian, et al.
Metabolites|February 3, 2021
Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?Florian Eude, Mathieu Nessim Toledano, Pierre Vera, et al.
Leukemia & Lymphoma|December 8, 2020
SUV<sub>max</sub>-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin's lymphomaEdgar Texte, Justine Lequesne, Hervé Tilly, et al.
Clinical Nuclear Medicine|December 14, 2020
Panniculitis in a Woman With Opportunistic Pulmonary Coinfection by Pneumocystis jirovecii and Cryptococcus neoformans: 18F-FDG PET/CT Revealing the Infection and Assessing Treatment ResponseBillal Tedbirt, Anne-Benedicte Duval-Modeste, Philippe Courville, et al.
Pageof 15